3,373
Views
29
CrossRef citations to date
0
Altmetric
Report

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms

, , , , &
Pages 389-404 | Received 06 Jul 2015, Accepted 26 Oct 2015, Published online: 20 Jan 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ethan M. Shevach. (2017) Garp as a therapeutic target for modulation of T regulatory cell function. Expert Opinion on Therapeutic Targets 21:2, pages 191-200.
Read now

Articles from other publishers (28)

Rohan Diwanji, Neil A. O'Brien, Jiyoung E. Choi, Beverly Nguyen, Tyler Laszewski, Angelo L. Grauel, Zheng Yan, Xin Xu, Jincheng Wu, David A. Ruddy, Michelle Piquet, Marc R. Pelletier, Alexander Savchenko, LaSalette Charette, Vanessa Rodrik-Outmezguine, Jason Baum, John M. Millholland, Connie C. Wong, Anne-Marie Martin, Glenn Dranoff, Iulian Pruteanu-Malinici, Viviana Cremasco, Catherine Sabatos-Peyton & Pushpa Jayaraman. (2023) Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses. Cancer Immunology Research 11:6, pages 777-791.
Crossref
Mirna Burciaga-Flores, Ana Laura Márquez-Aguirre, Salvador Dueñas, Jahaziel Gasperin-Bulbarela, Alexei F. Licea-Navarro & Tanya A. Camacho-Villegas. (2023) First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment. Scientific Reports 13:1.
Crossref
Christianne Groeneveldt, Jurriaan Q. van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie, Diana J.M. van den Wollenberg, Rob C. Hoeben, Sjoerd H. van der Burg, Peter ten Dijke, Lukas J.A.C. Hawinkels, Thorbald van Hall & Nadine van Montfoort. (2023) Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy. Cancer Research Communications 3:2, pages 325-337.
Crossref
Christine G. Shao, Nishant R. Sinha, Rajiv R. Mohan & Aaron D. Webel. (2023) Novel Therapies for the Prevention of Fibrosis in Glaucoma Filtration Surgery. Biomedicines 11:3, pages 657.
Crossref
Qian Ruan, Xuezhen Lin, Lixia Wang, Niu Wang, Yu Zhao, Hao Wang, Fu-Ying Tian, Ning Hu, Ying Li & Bo Zhao. (2023) An engineered (CAGA)12-EGFP cell-based biosensor for high-content and accurate detection of active TGF-β. Biosensors and Bioelectronics 220, pages 114884.
Crossref
K. Yamaura, A.L. Nelson, H. Nishimura, J.C. Rutledge, S.K. Ravuri, C. Bahney, M.J. Philippon & J. Huard. (2022) The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review. Osteoarthritis and Cartilage.
Crossref
Max Kam-Kwan Chan, Jeff Yat-Fai Chung, Philip Chiu-Tsun Tang, Alex Siu-Wing Chan, Johnny Yuk-Yeung Ho, Tony Pak-Tik Lin, Jiaoyi Chen, Kam-Tong Leung, Ka-Fai To, Hui-Yao Lan & Patrick Ming-Kuen Tang. (2022) TGF-β signaling networks in the tumor microenvironment. Cancer Letters 550, pages 215925.
Crossref
Aadhya Tiwari, Rakesh Trivedi & Shiaw-Yih Lin. (2022) Tumor microenvironment: barrier or opportunity towards effective cancer therapy. Journal of Biomedical Science 29:1.
Crossref
Nicholas P. Tschernia & James L. Gulley. (2022) Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy. BioDrugs 36:2, pages 153-180.
Crossref
Daniele V. F. Tauriello, Elena Sancho & Eduard Batlle. (2021) Overcoming TGFβ-mediated immune evasion in cancer. Nature Reviews Cancer 22:1, pages 25-44.
Crossref
Xiaofeng Dai, Dong Hua & Xiaoxia Lu. (2022) Roles of TGF- β in cancer hallmarks and emerging onco-therapeutic design . Expert Reviews in Molecular Medicine 24.
Crossref
Pedro Caetano Pinto, Cindy Rönnau, Martin Burchardt & Ingmar Wolff. (2021) Kidney Cancer and Chronic Kidney Disease: Too Close for Comfort. Biomedicines 9:12, pages 1761.
Crossref
Peng Jiang, Yu Zhang, Beibei Ru, Yuan Yang, Trang Vu, Rohit Paul, Amer Mirza, Grégoire Altan-Bonnet, Lingrui Liu, Eytan Ruppin, Lalage Wakefield & Kai W. Wucherpfennig. (2021) Systematic investigation of cytokine signaling activity at the tissue and single-cell levels. Nature Methods 18:10, pages 1181-1191.
Crossref
Marcela Soledad Bertolio, Anabela La Colla, Alejandra Carrea, Ana Romo, Gabriela Canziani, Stella Maris Echarte, Sabrina Campisano, German Patricio Barletta, Alexander Miguel Monzon, Tania Melina Rodríguez, Andrea Nancy Chisari & Ricardo Alfredo Dewey. (2021) A Novel Splice Variant of Human TGF-β Type II Receptor Encodes a Soluble Protein and Its Fc-Tagged Version Prevents Liver Fibrosis in vivo. Frontiers in Cell and Developmental Biology 9.
Crossref
Fabio Sabbadini, Monica Bertolini, Serena De Matteis, Domenico Mangiameli, Serena Contarelli, Silvia Pietrobono & Davide Melisi. (2021) The Multifaceted Role of TGF-β in Gastrointestinal Tumors. Cancers 13:16, pages 3960.
Crossref
Samia Rahman, Alexander R. A. Szojka, Yan Liang, Melanie Kunze, Victoria Goncalves, Aillette Mulet-Sierra, Nadr M. Jomha & Adetola B. Adesida. (2021) Inability of Low Oxygen Tension to Induce Chondrogenesis in Human Infrapatellar Fat Pad Mesenchymal Stem Cells. Frontiers in Cell and Developmental Biology 9.
Crossref
Yun Yang, Wen-Long Ye, Ruo-Nan Zhang, Xiao-Shun He, Jing-Ru Wang, Yu-Xuan Liu, Yi Wang, Xue-Mei Yang, Yu-Juan Zhang & Wen-Juan Gan. (2021) The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-16.
Crossref
Erine H Budi, Johanna R Schaub, Martin Decaris, Scott Turner & Rik Derynck. (2021) TGF ‐β as a driver of fibrosis: physiological roles and therapeutic opportunities . The Journal of Pathology 254:4, pages 358-373.
Crossref
Alba Gonzalez-Junca, Oliver Reiners, Luis D. Borrero-Garcia, Denis Beckford-Vera, Ann A. Lazar, William Chou, Steve Braunstein, Henry VanBrocklin, Benjamin L. Franc & Mary Helen Barcellos-Hoff. (2021) Positron Emission Tomography Imaging of Functional Transforming Growth Factor β (TGFβ) Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors. International Journal of Radiation Oncology*Biology*Physics 109:2, pages 527-539.
Crossref
Jahaziel Gasperin-Bulbarela, Ana B. Castro-Ceseña, Tanya Camacho-Villegas, Pavel H. Lugo-Fabres, Nestor Emmanuel Díaz-Martínez, Eduardo Padilla-Camberos, Raquel Echavarría & Alexei F. Licea-Navarro. (2021) Ca-Alginate-PEGMA Hydrogels for In Situ Delivery of TGF-β Neutralizing Antibodies in a Mouse Model of Wound Healing. Applied Sciences 11:3, pages 1164.
Crossref
Rik Derynck, Shannon J. Turley & Rosemary J. Akhurst. (2020) TGFβ biology in cancer progression and immunotherapy. Nature Reviews Clinical Oncology 18:1, pages 9-34.
Crossref
Angelo L. Grauel, Beverly Nguyen, David Ruddy, Tyler Laszewski, Stephanie Schwartz, Jonathan Chang, Julie Chen, Michelle Piquet, Marc Pelletier, Zheng Yan, Nathaniel D. Kirkpatrick, Jincheng Wu, Antoine deWeck, Markus Riester, Matt Hims, Felipe Correa Geyer, Joel Wagner, Kenzie MacIsaac, James Deeds, Rohan Diwanji, Pushpa Jayaraman, Yenyen Yu, Quincey Simmons, Shaobu Weng, Alina Raza, Brian Minie, Mirek Dostalek, Pavitra Chikkegowda, Vera Ruda, Oleg Iartchouk, Naiyan Chen, Raphael Thierry, Joseph Zhou, Iulian Pruteanu-Malinici, Claire Fabre, Jeffrey A. Engelman, Glenn Dranoff & Viviana Cremasco. (2020) TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts. Nature Communications 11:1.
Crossref
Mohamed A. Alfaleh, Hashem O. Alsaab, Ahmad Bakur Mahmoud, Almohanad A. Alkayyal, Martina L. Jones, Stephen M. Mahler & Anwar M. Hashem. (2020) Phage Display Derived Monoclonal Antibodies: From Bench to Bedside. Frontiers in Immunology 11.
Crossref
Constance J. Martin, Abhishek DattaChristopher LittlefieldAshish KalraChristopher ChapronStefan WawersikKevin B. Dagbay, Christopher T. Brueckner, Anastasia Nikiforov, Francis T. DanehyJr.Jr., Frederick C. StreichJr.Jr., Christopher Boston, Allison Simpson, Justin W. Jackson, Susan Lin, Nicole Danek, Ryan R. FaucettePichai RamanAllan D. Capili, Alan Buckler, Gregory J. Carven & Thomas Schürpf. (2020) Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape. Science Translational Medicine 12:536.
Crossref
Anne-Ulrike Trendelenburg. 2020. Anti-fibrotic Drug Discovery. Anti-fibrotic Drug Discovery 1 36 .
Mahesh Kandasamy, Muthuswamy Anusuyadevi, Kiera M Aigner, Michael S Unger, Kathrin M Kniewallner, Diana M Bessa de Sousa, Barbara Altendorfer, Heike Mrowetz, Ulrich Bogdahn & Ludwig Aigner. (2020) TGF-β Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia?. Aging and disease 11:4, pages 828.
Crossref
E. Dodagatta-Marri, D. S. Meyer, M. Q. Reeves, R. Paniagua, M. D. To, M. Binnewies, M. L. Broz, H. Mori, D. Wu, M. Adoumie, R. Del Rosario, O. Li, T. Buchmann, B. Liang, J. Malato, F. Arce Vargus, D. Sheppard, B. C. Hann, A. Mirza, S. A. Quezada, M. D. Rosenblum, M. F. Krummel, A. Balmain & R. J. Akhurst. (2019) α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Rosemary J. Akhurst. (2017) Targeting TGF-β Signaling for Therapeutic Gain. Cold Spring Harbor Perspectives in Biology 9:10, pages a022301.
Crossref